ProCE Banner Activity

Changing TKIs Due To Intolerance: Second-Line Therapy and Toxicity Management

Slideset Download
Downloadable slides with expert analysis of CML management after TKI inhibitor intolerance.

Released: June 17, 2020

Expiration: June 16, 2021

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Pfizer, Inc.

Faculty Disclosure

Primary Author

Carlo Gambacorti-Passerini, MD

Professor, Hematology
University Milano Bicocca
Director, Hematology
San Gerardo Hospital
Monza, Italy